Back to Journals » Clinical Interventions in Aging » Volume 11

The association between gastric acid inhibitors and delirium in geriatric inpatients: implications for clinical practice and research

Authors Zhu LL, Zhou Q

Received 23 April 2016

Accepted for publication 29 April 2016

Published 16 June 2016 Volume 2016:11 Pages 797—799

DOI https://doi.org/10.2147/CIA.S111202

Checked for plagiarism Yes

Editor who approved publication: Professor Zhi-Ying Wu

Ling-ling Zhu,1 Quan Zhou2

1VIP Care Ward, Division of Nursing, the Second Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou, Zhejiang Province, People’s Republic of China; 2Department of Pharmacy, the Second Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou, Zhejiang Province, People’s Republic of China

We read with great interest the prospective observational study by Otremba et al,1 which shows that use of proton-pump inhibitors (PPIs) is one of independent factors associated with development of delirium in geriatric inpatients (odds ratio [OR] =1.67; confidence interval [CI] =1.11–2.53; P=0.014). We especially appreciate their new finding, because PPIs are commonly prescribed in older hospitalized patients. However, we found two points worthy of discussion and we would like to share our perspectives in the following paragraphs.

View original paper by Otremba and colleagues.

Creative Commons License This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License. By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.

Download Article [PDF]  View Full Text [HTML][Machine readable]

 

Other articles by this author:

Weight-based dosing in medication use: what should we know?

Pan SD, Zhu LL, Chen M, Xia P, Zhou Q

Patient Preference and Adherence 2016, 10:549-560

Published Date: 12 April 2016

A stewardship intervention program for safe medication management and use of antidiabetic drugs

Zhao RY, He XW, Shan YM, Zhu LL, Zhou Q

Clinical Interventions in Aging 2015, 10:1201-1212

Published Date: 23 July 2015

The optimal choice of medication administration route regarding intravenous, intramuscular, and subcutaneous injection

Jin JF, Zhu LL, Chen M, Xu HM, Wang HF, Feng XQ, Zhu XP, Zhou Q

Patient Preference and Adherence 2015, 9:923-942

Published Date: 2 July 2015

Pharmacokinetic drug interactions with clopidogrel: updated review and risk management in combination therapy

Wang ZY, Chen M, Zhu LL, Yu LS, Zeng S, Xiang MX, Zhou Q

Therapeutics and Clinical Risk Management 2015, 11:449-467

Published Date: 19 March 2015

Personalized therapeutics for levofloxacin: a focus on pharmacokinetic concerns

Gao CH, Yu LS, Zeng S, Huang YW, Zhou Q

Therapeutics and Clinical Risk Management 2014, 10:217-227

Published Date: 27 March 2014

Appropriateness of administration of nasogastric medication and preliminary intervention

Zhu LL, Xu LC, Wang HQ, Jin JF, Wang HF, Zhou Q

Therapeutics and Clinical Risk Management 2012, 8:393-401

Published Date: 20 November 2012